Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul Michael Copeland, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957. PMID: 30747254.
    Citations:    
  2. Luo Y, Liu F, Natarajan R, Shukair N, Copeland P, Fan X. Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a pilot study. Int Clin Psychopharmacol. 2018 03; 33(2):88-91. PMID: 29084087.
    Citations:    Fields:    Translation:Humans
  3. Nemani KL, Greene MC, Ulloa M, Vincenzi B, Copeland PM, Al-Khadari S, Henderson DC. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. Clin Schizophr Relat Psychoses. 2019 Winter; 12(4):168-176. PMID: 29164928.
    Citations:    Fields:    
  4. Henderson DC, Vincenzi B, Andrea NV, Ulloa M, Copeland PM. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015 May; 2(5):452-464. PMID: 26360288.
    Citations: 19     Fields:    Translation:Humans
  5. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403. PMID: 25261882.
    Citations: 5     Fields:    Translation:Humans
  6. Vincenzi B, Borba CP, Gray DA, Copeland PM, Wang X, Fan X, Aragam GG, Henderson DC. An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics. Ann Clin Psychiatry. 2013 May; 25(2):141-8. PMID: 23638445.
    Citations: 5     Fields:    Translation:Humans
  7. Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30. PMID: 23422397.
    Citations: 1     Fields:    Translation:Humans
  8. Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5. PMID: 23434504.
    Citations: 3     Fields:    Translation:Humans
  9. Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26. PMID: 22943577.
    Citations: 9     Fields:    Translation:Humans
  10. Borba CP, Fan X, Copeland PM, Paiva A, Freudenreich O, Henderson DC. Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. J Clin Psychopharmacol. 2011 Oct; 31(5):653-8. PMID: 21869685.
    Citations: 6     Fields:    Translation:Humans
  11. Henderson DC, Freudenreich O, Borba CP, Wang X, Copeland PM, Macklin E, Fan X, Cather C, Goff DC. Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):53-6. PMID: 21565464.
    Citations: 4     Fields:    Translation:Humans
  12. Fan X, Copeland PM, Liu EY, Chiang E, Freudenreich O, Goff DC, Henderson DC. No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia. J Clin Psychopharmacol. 2011 Apr; 31(2):231-4. PMID: 21346605.
    Citations: 4     Fields:    Translation:Humans
  13. Henderson DC, Sharma B, Fan X, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. Ann Clin Psychiatry. 2010 Feb; 22(1):33-42. PMID: 20196981.
    Citations: 5     Fields:    Translation:Humans
  14. Cole A, Nathan DM, Savaria-Porter E, Copeland P, Turchin A, Brunt M, Zusman R, Barrett JA, Wexler D, Case E, McMahon GT, Mort E. An algorithm for the care of type 2 diabetes. Crit Pathw Cardiol. 2009 Dec; 8(4):156-65. PMID: 19952550.
    Citations: 2     Fields:    Translation:Humans
  15. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract. 2009 Jul; 15(4):251-61. PMID: 19625881.
    Citations: 3     Fields:    Translation:Humans
  16. Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. J Clin Psychopharmacol. 2009 Apr; 29(2):165-9. PMID: 19512978.
    Citations: 10     Fields:    Translation:Humans
  17. Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Forstbauer SI, Miley K, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia. Hum Psychopharmacol. 2009 Apr; 24(3):225-32. PMID: 19283774.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  18. Miller JC, Blake MA, Boland GW, Copeland PM, Thrall JH, Lee SI. Adrenal masses. J Am Coll Radiol. 2009 Mar; 6(3):206-11. PMID: 19248999.
    Citations:    Fields:    Translation:Humans
  19. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Boxill R, Freudenreich O, Cather C, Eden Evins A, Goff DC. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. Acta Psychiatr Scand. 2009 Jun; 119(6):457-65. PMID: 19183127.
    Citations: 10     Fields:    Translation:Humans
  20. Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry. 2007 Apr; 68(4):533-41. PMID: 17474808.
    Citations: 15     Fields:    Translation:Humans
  21. Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatr Scand. 2007 Feb; 115(2):101-5. PMID: 17244173.
    Citations: 15     Fields:    Translation:Humans
  22. Copeland PM. How successful are commercial weight-loss programs? Nat Clin Pract Endocrinol Metab. 2006 Dec; 2(12):658-9. PMID: 17143308.
    Citations:    Fields:    
  23. Fan X, Anderson EJ, Copeland PM, Borba CP, Nguyen DD, Freudenreich O, Goff DC, Henderson DC. Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients. Biol Psychiatry. 2006 Dec 15; 60(12):1372-7. PMID: 16920075.
    Citations: 4     Fields:    Translation:Humans
  24. Slattery JM, Blake MA, Kalra MK, Misdraji J, Sweeney AT, Copeland PM, Mueller PR, Boland GW. Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol. 2006 Jul; 187(1):W21-4. PMID: 16794135.
    Citations: 12     Fields:    Translation:Humans
  25. Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psychiatry. 2006 May; 67(5):789-97. PMID: 16841629.
    Citations: 12     Fields:    Translation:Humans
  26. Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Eden Evins A, Freudenreich O, Baer L, Goff DC. Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb; 113(2):121-5. PMID: 16423163.
    Citations: 4     Fields:    Translation:Humans
  27. Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry. 2005 Sep; 66(9):1116-21. PMID: 16187768.
    Citations: 33     Fields:    Translation:Humans
  28. Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. Am J Psychiatry. 2005 May; 162(5):954-62. PMID: 15863798.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  29. Ormerod AD, Shah SA, Copeland P, Omar G, Winfield A. Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial. Br J Dermatol. 2005 Apr; 152(4):758-64. PMID: 15840110.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  30. Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005 Feb; 66(2):183-94; quiz 147, 273-4. PMID: 15705003.
    Citations: 62     Fields:    Translation:HumansPHPublic Health
  31. Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins AE, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry. 2005 01; 62(1):19-28. PMID: 15630069.
    Citations: 74     Fields:    Translation:Humans
  32. Copeland PM. Management of the clinically inapparent adrenal mass. Ann Intern Med. 2004 Mar 02; 140(5):401; author reply 401-2. PMID: 14996684.
    Citations: 1     Fields:    Translation:Humans
  33. Ormerod AD, Copeland P, Shah SA. Treatment of psoriasis with topical NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Br J Dermatol. 2000 May; 142(5):985-90. PMID: 10809860.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  34. Copeland PM. Adrenal incidentaloma. Curr Ther Endocrinol Metab. 1997; 6:189-94. PMID: 9174735.
    Citations:    Fields:    Translation:Humans
  35. Copeland PM. Two cases of therapeutic failure associated with levothyroxine brand interchange. Ann Pharmacother. 1995 May; 29(5):482-5. PMID: 7655130.
    Citations: 4     Fields:    Translation:Humans
  36. Copeland PM, Sacks NR, Herzog DB. Longitudinal follow-up of amenorrhea in eating disorders. Psychosom Med. 1995 Mar-Apr; 57(2):121-6. PMID: 7792370.
    Citations: 5     Fields:    Translation:Humans
  37. Copeland PM. Renal failure associated with laxative abuse. Psychother Psychosom. 1994; 62(3-4):200-2. PMID: 7531354.
    Citations: 10     Fields:    Translation:Humans
  38. Fava M, Copeland PM, Schweiger U, Herzog DB. Neurochemical abnormalities of anorexia nervosa and bulimia nervosa. Am J Psychiatry. 1989 Aug; 146(8):963-71. PMID: 2568763.
    Citations: 12     Fields:    Translation:Humans
  39. Copeland PM. Diuretic abuse and central pontine myelinolysis. Psychother Psychosom. 1989; 52(1-3):101-5. PMID: 2486385.
    Citations: 2     Fields:    Translation:Humans
  40. Herzog DB, Copeland PM. Bulimia nervosa--psyche and satiety. N Engl J Med. 1988 Sep 15; 319(11):716-8. PMID: 3412390.
    Citations:    Fields:    Translation:Humans
  41. Copeland PM, Herzog DB, Carr DB, Klibanski A, MacLaughlin RA, Martin JB. Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal women. Psychoneuroendocrinology. 1988; 13(3):273-8. PMID: 3406324.
    Citations: 2     Fields:    Translation:Humans
  42. Copeland PM, Herzog DB. Hypoglycemia and death in anorexia nervosa. Psychother Psychosom. 1987; 48(1-4):146-50. PMID: 3505707.
    Citations: 4     Fields:    Translation:Humans
  43. Copeland PM, Herzog DB. Non-bulimia: food regurgitation in a patient with self-diagnosed bulimia. J Clin Psychiatry. 1986 Jun; 47(6):317-8. PMID: 3086293.
    Citations:    Fields:    Translation:Humans
  44. Copeland PM, Martin JB, Ridgway EC. Cysteamine decreases prolactin responsiveness to thyrotropin-releasing hormone in normal men. Am J Med Sci. 1986 Jan; 291(1):16-9. PMID: 3079953.
    Citations: 1     Fields:    Translation:Humans
  45. Herzog DB, Copeland PM. Eating disorders. N Engl J Med. 1985 Aug 01; 313(5):295-303. PMID: 2861566.
    Citations: 28     Fields:    Translation:Humans
  46. Copeland PM. The incidentally discovered adrenal mass. Ann Surg. 1984 Jan; 199(1):116-22. PMID: 6691725.
    Citations: 9     Fields:    Translation:Humans
  47. Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med. 1983 Jun; 98(6):940-5. PMID: 6344711.
    Citations: 46     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Copeland's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (242)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.